Average Co-Inventor Count = 5.80
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Acelrx Pharmaceuticals, Inc. (21 from 26 patents)
2. Sinusys Corporation (7 from 8 patents)
3. Acelrx Pharmaceutical, Inc. (1 from 1 patent)
29 patents:
1. 10709881 - Apparatus for administering small volume oral transmucosal dosage forms
2. 10507180 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
3. 10342762 - Small-volume oral transmucosal dosage forms
4. 10245228 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
5. 9744129 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
6. 9687263 - Devices and methods for inserting a sinus dilator
7. 9642996 - Methods and apparatus for administering small volume oral transmucosal dosage forms
8. 9629644 - Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
9. 9597485 - Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
10. 9504812 - Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
11. 9498239 - Devices and methods for inserting a sinus dilator
12. 9320710 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
13. 9289583 - Methods for administering small volume oral transmucosal dosage forms using a dispensing device
14. 9149616 - Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
15. 9138569 - Devices and methods for dilating a paranasal sinus opening and for treating sinusitis